Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Okedi
Treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
